ciprotabs 500 mg filmovertrukne tabletter
aliud pharma gmbh & co. kg - ciprofloxacinhydrochlorid, vandfrit - filmovertrukne tabletter - 500 mg
ciprotabs 750 mg filmovertrukne tabletter
aliud pharma gmbh & co. kg - ciprofloxacinhydrochlorid, vandfrit - filmovertrukne tabletter - 750 mg
myrciprox 500 mg filmovertrukne tabletter
ratiopharm gmbh - ciprofloxacinhydrochlorid, vandfrit - filmovertrukne tabletter - 500 mg
ciprinomyl 400 mg/200 ml infusionsvæske, opløsning
mylan ab - ciprofloxacin - infusionsvæske, opløsning - 400 mg/200 ml
ciproscope 250 mg filmovertrukne tabletter
teva pharma b.v. - ciprofloxacin - filmovertrukne tabletter - 250 mg
ciproscope 500 mg filmovertrukne tabletter
teva pharma b.v. - ciprofloxacin - filmovertrukne tabletter - 500 mg
ciproten 250 mg filmovertrukne tabletter
abz pharma gmbh - ciprofloxacin - filmovertrukne tabletter - 250 mg
ciproten 500 mg filmovertrukne tabletter
abz pharma gmbh - ciprofloxacin - filmovertrukne tabletter - 500 mg
paraxal duo 3+0,25 mg/ml øredråber, opløsning
paranova danmark a/s - ciprofloxacin, fluocinolonacetonid - øredråber, opløsning - 3+0,25 mg/ml
renagel
sanofi b.v. - sevelamer - renal dialysis; hyperphosphatemia - alle andre terapeutiske produkter - renagel is indicated for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis. renagel should be used within the context of a multiple therapeutic approach, which could include calcium supplements, 1,25 - dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.